Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 401–500 of 1,000
West Nile Virus Infection in the Central Nervous System
Winkelmann, E. R., Luo, H., & Wang, T. (2016) · F1000Research · doi:10.12688/f1000research.7404.1 · Cited by 62
Inhibition of hepatitis C virus protein expression by RNA interference
Sen, A., Steele, R., Ghosh, A. K., Basu, A., RAY, R. K., & Ray, R. B. (2003) · Virus Research · doi:10.1016/s0168-1702(03)00170-9 · Cited by 64
Yu, J.-S., Tseng, C.-K., Lin, C., Hsu, Y., Wu, Y., Hsieh, C., & Lee, J. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.010 · Cited by 64
“…antiviral IFN responses through the JAKeSTAT pathway IFN-a interacts with cell surface IFN-a receptors and activates Jak1 and Tyk2 kinases (Fink and Grandvaux, 2013; Katze et al., 2002), leading to the phosphorylation and translocation of STAT1/ 2 (Darnell, 1997; Schindler and Strehlow, 2000).”
BackgroundInfluenza A virus interacts extensively with the cellular SUMOylation system during infection
Pal, S., Santos, A., Rosas, J. M., Ortiz‐Guzman, J., & Rosas-Acosta, G. (2011) · Virus Research · doi:10.1016/j.virusres.2011.02.017 · Cited by 63
Lee, L. N., Burke, S., Montoya, M., & Borrow, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802526 · Cited by 66
“Possible explanations for this may include down-regulation of type 1 IFN production by host homeostatic mechanisms invoked to prevent detrimental consequences of continuous exposure to high levels of type 1 IFN (22) and/or impairment of type 1 IFN production as a consequence of virus persistence, which may be actively…”
BackgroundKumova, O. K., Fike, A. J., Thayer, J. L., Nguyen, L. T., Mell, J. C., Pascasio, J. M., Stairiker, C. J., León, L. G., Katsikis, P. D., & Carey, A. J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008072 · Cited by 69
Mechanism of the interferon alpha response against hepatitis C virus replicons
Guo, J., Sohn, J. A., Zhu, Q., & Seeger, C. (2004) · Virology · doi:10.1016/j.virol.2004.04.031 · Cited by 66
Glioma-initiating cells and molecular pathology: implications for therapy
Natsume, A., Kinjo, S., Yuki, K., Kato, T., Ohno, M., Motomura, K., Iwami, K., & Wakabayashi, T. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0011-3 · Cited by 65
“L system, adenosine deaminase ADR1, and Mx guanosine triphosphatase (GTPase) [ 66 ]; thus, RNAi may be involved in IFN-mediated antiviral response.”
Interaction of Hepatitis C virus proteins with pattern recognition receptors
Imran, M., Waheed, Y., Manzoor, S., Bilal, M., Ashraf, W., Ali, M., & Ashraf, M. (2012) · Virology Journal · doi:10.1186/1743-422x-9-126 · Cited by 65
“Many viruses have evolved the strategy to impede the effector mechanisms induced through these pathways [60], but viral interference with the significant proximal receptor interactions has not yet been depicted.”
BackgroundUetani, K., Hiroi, M., MEGURO, T., Ogawa, H., Kamisako, T., Ohmori, Y., & ERZURUM, S. C. (2008) · European Journal of Immunology · doi:10.1002/eji.200737045 · Cited by 67
Herbst‐Kralovetz, M. M., & Pyles, R. B. (2006) · Journal of Virology · doi:10.1128/jvi.01099-06 · Cited by 65
“IFN- directly inhibits HSV-2 gene expression and activates other immune system components, including antigen-presenting cells and lymphocytes (23, 24).”
BackgroundMethodBclaf1 critically regulates the type I interferon response and is degraded by alphaherpesvirus US3
Qin, C., Zhang, R., Lang, Y., Shao, A., Xu, A., Feng, W., Han, J., Wang, M., He, W., Yu, C., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007559 · Cited by 63
Varicella Zoster Virus Immune Evasion Strategies
Abendroth, A., Kinchington, P. R., & Slobedman, B. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_41 · Cited by 65
“In response to virus infection, a variety of signal transduction pathways are activated by the innate responses, including the expression of type I IFNs (i.e., IFN α/β), that induce a large number of IFN-stimulated genes, leading to an antiviral state.”
BackgroundInfluentialBarnett, P. V., Keel, P., Reid, S. M., Armstrong, R. M., Statham, R. J., Voyce, C., Aggarwal, N., & Cox, S. J. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.09.024 · Cited by 61
Respiratory Syncytial Virus-Induced Immunoprotection and Immunopathology
Durbin, J. E., & Durbin, R. K. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.370 · Cited by 64
Khan, Z., Mehan, S., Gupta, G. D., & Narula, A. S. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.04.004 · Cited by 67
Use of recombinant interferon omega in feline retrovirosis: From theory to practice
Doménech, A., Miró, G., Collado, V. M., Ballesteros, N. A., Sanjosé, L., Escolar, E., Martin, S., & Gómez‐Lucía, E. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.008 · Cited by 60
Antonsson, A., Payne, E., Hengst, K., & McMillan, N. A. J. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.455 · Cited by 68
Recombinant Poliovirus for Cancer Immunotherapy
Gromeier, M., & Nair, S. K. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104655 · Cited by 68
“Arguably, the most important first line of host defense against virus infection is the innate antiviral interferon (IFN) response (52).”
BackgroundRecognition of infected cells by natural killer cells
Carayannopoulos, L. N., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.003 · Cited by 60
Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19
Rodrigo-Muñoz, J. M., Sastre, B., Cañas, J. A., Gil‐Martínez, M., Redondo, N., & del Pozo, V. (2020) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0624 · Cited by 61
“proven effects in the clearance of viral infections and thus show an alternative pathway by which eosinophils fight against viruses [67,68].”
BackgroundRNAi and Cellular miRNAs in Infections by Mammalian Viruses
Haasnoot, J., & Berkhout, B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-037-9_2 · Cited by 59
“For example, the Ebola virus VP35, influenza virus NS1, and vaccinia virus E3L proteins also act as antagonists of the cellular dsRNA sensors RNA helicases retinoic acid-inducible gene I (RIG-I), dsRNA-dependent protein kinase (PKR), or 2¢-5¢ oligo adenylate synthetase enzymes (OAS) (77) (78) (79) (80) (81) (82) (83)…”
BackgroundSantos, T. D. L., Wu, Q., Botton, S. D. Á., & Grubman, M. J. (2005) · Virology · doi:10.1016/j.virol.2005.03.001 · Cited by 59
Chicken interferons, their receptors and interferon-stimulated genes
Goossens, K. E., Ward, A. C., Lowenthal, J. W., & Bean, A. G. D. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.020 · Cited by 65
Transcriptome analysis of epithelioma papulosum cyprini cells after SVCV infection
Yuan, J. F., Yang, Y., Nie, H., Li, L., Gu, W.-G., Lin, L., Zou, M., Liu, X., Wang, M., & Gu, Z. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-935 · Cited by 61
“Viruses, which require cellular machinery for their replication, have evolved different strategies to counteract the action of IFN, particularly by the alteration of IFNsignaling and IFN-induced mediators that are required for virulence [31].”
BackgroundFever range temperature promotes TLR4 expression and signaling in dendritic cells
Yan, X., Xiu, F., An, H., Wang, X., Wang, J., & Cao, X. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.022 · Cited by 60
Volkova, E., Gorchakov, R. V., & Frolov, I. V. (2005) · Virology · doi:10.1016/j.virol.2005.09.010 · Cited by 60
Interferon Gene Expression following HIV Type 1 Infection of Monocyte-Derived Macrophages
Woelk, C. H., Ottonès, F., Plotkin, C. R., Du, P., Royer, C. D., Rought, S. E., Lozach, J., Šášik, R., Kornbluth, R. S., Richman, D. D., et al. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/0889222042545009 · Cited by 67
Toll-like receptors and innate immune responses in systemic lupus erythematosus
Lafyatis, R., & Marshak‐Rothstein, A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2321 · Cited by 59
“elaborate methods for inhibiting IFN or its signaling [62].”
Chaulagain, S., Delhon, G. A., Khatiwada, S., & Rock, D. L. (2021) · Viruses · doi:10.3390/v13081480 · Cited by 69
Immune responses in mildly versus critically ill COVID-19 patients
Nasrollahi, H., Talepoor, A. G., Saleh, Z., Vakili, M. E., Heydarinezhad, P., Karami, N., Noroozi, M., Meri, S., & Kalantar, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1077236 · Cited by 69
Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
Dey, P., Ahuja, A., Panwar, J., Choudhary, P., Rani, S., Kaur, M., Sharma, A., Kaur, J. K., Yadav, A. K., Sood, V., et al. (2023) · Vaccines · doi:10.3390/vaccines11030593 · Cited by 88
Regulation of Innate Immune Responses by Bovine Herpesvirus 1 and Infected Cell Protein 0 (bICP0)
Jones, C. (2009) · Viruses · doi:10.3390/v1020255 · Cited by 62
“The HHV-1 glycoprotein gD induces IFN- production in mononuclear cells [80], in part, because”
BackgroundDevaux, P., Hudacek, A. W., Hodge, G., Valle, J. R., McChesney, M. B., & Cattaneo, R. (2010) · Journal of Virology · doi:10.1128/jvi.00802-10 · Cited by 67
“They can interfere with gene expression and/or protein synthesis, minimize IFN induction by specifically blocking IFN induction cascades, inhibit IFN signaling, block the action of IFN-induced antiviral proteins, or have a replication strategy not sensitive to IFN action (19, 21, 24).”
BackgroundReynaud, J. M., Jégou, J., Welsch, J., & Horvat, B. (2014) · Journal of Virology · doi:10.1128/jvi.03763-13 · Cited by 58
“As IFN-I is important for the control of viral infections in the early stages (52, 56), we prepared primary brain cultures from either mice deficient for the expression of IFN-I receptor (IFNARKO mice) or CD46-cyt2 mice crossed into the IFNARKO background.”
MethodMenachery, V. D., & Baric, R. S. (2013) · Immunological Reviews · doi:10.1111/imr.12092 · Cited by 57
“Globally, ISGs as a class have broad functions beyond just direct viral antagonism including increased MHC class I and II expression, augmented immune infiltration and trafficking, and host protein shutoff (51).”
BackgroundDodd, K. A., Bird, B. H., Metcalfe, M. G., Nichol, S. T., & Albariño, C. G. (2012) · Journal of Virology · doi:10.1128/jvi.07104-11 · Cited by 61
“These genes stimulate the expression of important players in the cellular defense against viruses, including PKR, OAS, IRFs, MX1, and major histocompatibility complex (MHC) classes I and II (20).”
BackgroundImmunological determinants of the outcomes from primary hepatitis C infection
Post, J. J., Ratnarajah, S., & Lloyd, A. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8270-4 · Cited by 65
Austin, B. A., James, C. M., Silverman, R. H., & Carr, D. J. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1100 · Cited by 58
Cheng, Y., Lin, Y.-S., Chen, C., Tsai, T.-T., Tsai, C., Wu, Y., Ou, Y.-D., Chu, Y., Wang, J., Yu, C.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep32000 · Cited by 60
“In addition to STAT1, which is a well-known downstream TF of the type I IFN response induced by viral infection 16 , the activity of Nrf2/Nrf1 increased most significantly ( p 0.001) after DENV infection (Fig.”
InfluentialWynant, N., dos Santos, D. M. M. F., & Broeck, J. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-08043-5 · Cited by 64
Shen, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28681 · Cited by 58
Bousse, T. L., Chambers, R., Scroggs, R. A., Portner, A., & Takimoto, T. (2006) · Virus Research · doi:10.1016/j.virusres.2006.03.012 · Cited by 65
Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching
Cerutti, A., Qiao, X., & He, B. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01389.x · Cited by 60
“IFN-αsb elicits powerful antiviral activities in both virally infected and non-infected cell”
BackgroundThe rainbow trout (Oncorhynchus mykiss) interferon response in the ovary
Chaves-Pozo, E., Zou, J., Secombes, C. J., Cuesta, A., & Tafalla, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.030 · Cited by 67
Rice, A. D., Turner, P., Embury, J. E., Moldawer, L. L., Baker, H. V., & Moyer, R. W. (2010) · Journal of Virology · doi:10.1128/jvi.00254-10 · Cited by 65
“4B), and STAT-1 is a known member of the host immune response involving interferon activity (36, 42, 71).”
BackgroundDelputte, P., Breedam, W. V., Barbé, F., Reeth, K. V., & Nauwynck, H. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0001 · Cited by 74
“34,36,40 In this report, we did not observe viral evasion from the IFN response but rather IFN-dependent enhancement of infection which results from IFN-(cid:2) -mediated induction of the PRRSV receptor Sn.”
Karpala, A. J., Bingham, J., Schat, K. A., Chen, L., Donis, R. O., Lowenthal, J. W., & Bean, A. G. D. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0069 · Cited by 59
Recent Progress in Studies of Arterivirus- and Coronavirus-Host Interactions
Zhong, Y., Tan, Y. W., & Liu, D. X. (2012) · Viruses · doi:10.3390/v4060980 · Cited by 59
“The expression and induction of interferons from the cells occurs in response to viral insults and tumor growth [87].”
BackgroundInflammatory and oxidative stress in rotavirus infection
Guerrero, C., & Acosta, O. (2016) · World Journal of Virology · doi:10.5501/wjv.v5.i2.38 · Cited by 62
IFN-α Sensitizes Human Umbilical Vein Endothelial Cells to Apoptosis Induced by Double-Stranded RNA
Kaiser, W. J., Kaufman, J. L., & Offermann, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1699 · Cited by 64
“Discussion Coordinating a specific and measured defense against microbial infection depends in part upon the innate immune system’s ability to recognize pathogen-associated molecular patterns, with dsRNA representing a molecular pattern common to most viral infections (11, 35, 80).”
BackgroundPharmacologic and Chemical Adjuvants in Tumor Virotherapy
Alvarez-Breckenridge, C. A., Kaur, B., & Chiocca, E. A. (2009) · Chemical Reviews · doi:10.1021/cr900048k · Cited by 60
Subversion of cytokine networks by virally encoded decoy receptors
Epperson, M. L., Lee, C. A., & Fremont, D. H. (2012) · Immunological Reviews · doi:10.1111/imr.12009 · Cited by 57
Immunity to betanodavirus infections of marine fish
Chen, Y.-M., Wang, T., & Chen, T.-Y. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.07.019 · Cited by 54
Pang, P. S., Planet, P. J., & Glenn, J. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006579 · Cited by 59
“There currently exists no systematic explanation for these genotype-specific differences in clinical outcome [4,9,10].”
BackgroundRegulation of Translation Initiation under Biotic and Abiotic Stresses
Echevarría‐Zomeño, S., Yángüez, E., Fernández‐Bautista, N., Castro‐Sanz, A. B., Ferrando, A., & Castellano, M. M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034670 · Cited by 56
Role of Herpes Simplex Virus 1 γ34.5 in the Regulation of IRF3 Signaling
Manivanh, R. V., Mehrbach, J., Knipe, D. M., & Leib, D. A. (2017) · Journal of Virology · doi:10.1128/jvi.01156-17 · Cited by 55
STAT3 induces anti-hepatitis C viral activity in liver cells
Zhu, H., Shang, X., Terada, N., & Liu, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.081 · Cited by 60
Hepatitis C Virus Inhibits Intracellular Interferon Alpha Expression in Human Hepatic Cell Lines *
Zhang, T., Lin, R., Li, Y., Douglas, S. D., Maxcey, C., Ho, C., Lai, J.-P., Wang, Y., Wan, Q., & Ho, W. (2005) · Hepatology · doi:10.1002/hep.20854 · Cited by 63
Henderson, G., Zhang, Y., & Jones, C. (2005) · Journal of General Virology · doi:10.1099/vir.0.81109-0 · Cited by 54
“The viral glycoprotein gD induces IFN-a production in mononuclear cells, leading to IFN response factor 3 (IRF3) activation (Katze et al., 2002).”
BackgroundResultInfluentialVarani, S., Frascaroli, G., Landini, M. P., & Söderberg‐Nauclér, C. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.609 · Cited by 60
Ohno, M., Natsume, A., Kondo, Y., Iwamizu, H., Motomura, K., Toda, H., Ito, M., Kato, T., & Wakabayashi, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0319 · Cited by 58
Weiss, G., Maaetoft‐Udsen, K., Stifter, S. A., Hertzog, P. J., Goriely, S., Thomsen, A. R., Paludan, S. R., & Frøkiær, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103491 · Cited by 53
“Secreted type I IFN signals through a ubiquitously expressed two-chain receptor (IFNAR), thereby initiating a signaling cascade that triggers the expression of numerous anti-viral, anti-bacterial, and immunoregulatory IFNstimulated genes (ISGs) involved in the innate host response (3).”
BackgroundAntiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation
Tortorec, A. L., Denis, H., Satié, A.-P., Patard, J. J., Ruffault, A., Jégou, B., & Dejucq‐Rainsford, N. (2008) · Human Reproduction · doi:10.1093/humrep/den207 · Cited by 54
“However, some viruses have evolved mechanisms to counteract the antiviral host responses (Stark et al., 1998; Goodbourn et al., 2000; Sen, 2001; Katze et al., 2002).”
BackgroundMethodInfluentialPeng, W., Henderson, G., Inman, M., BenMohamed, L., Perng, G., Wechsler, S. L., & Jones, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6162-6171.2005 · Cited by 58
Correy, G. J., Kneller, D. W., Phillips, G., Pant, S., Russi, S., Cohen, A. E., Meigs, G., Holton, J. M., Gahbauer, S., Thompson, M. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo5083 · Cited by 52
Pacheco, N. G., Ibáñez-Salazar, A., Oostdam, A. S. H.-V., Oropeza-Valdez, J. J., Magaña-Aquino, M., López, J. A., Monárrez‐Espino, J., & López‐Hernández, Y. (2022) · Diagnostics · doi:10.3390/diagnostics13010133 · Cited by 58
Antiviral action of the tumor suppressor ARF
García, M. Á., Collado, M., Muñoz‐Fontela, C., Matheu, A., Marcos-Villar, L., Arroyo, J., Estéban, M., Serrano, M., & Rivas, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601302 · Cited by 62
“Viral infection is the cause of cellular stress and the IFN system is the first barrier against viruses (Katze et al, 2002).”
BackgroundInterferon-mediated ISG15 conjugation restricts dengue virus 2 replication
Hishiki, T., Han, Q., Arimoto, K., Shimotohno, K., Igarashi, T., Vasudevan, S. G., Suzuki, Y., & Yamamoto, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.081 · Cited by 51
Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules
Berg, T. (2008) · ChemBioChem · doi:10.1002/cbic.200800274 · Cited by 53
Naka, K., Dansako, H., Kobayashi, N., Ikeda, M., & Kato, N. (2005) · Virology · doi:10.1016/j.virol.2005.10.023 · Cited by 53
Balmelli, C., Vincent, I., Henriette Rau, A., Guzylack‐Piriou, L., McCullough, K. C., & Summerfield, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200525998 · Cited by 53
El-mayet, F. S., Sawant, L., Thunuguntla, P., & Jones, C. (2017) · Journal of Virology · doi:10.1128/jvi.00904-17 · Cited by 50
Leang, R. S., Wu, T.-T., Hwang, S., Liang, L. T., Tong, L. M., Truong, J., & Sun, R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002292 · Cited by 57
“Furthermore, the type I IFN response is critical in shaping the adaptive immune response [1,2,6,9,36].”
BackgroundInfluentialPolymeric Micelles in Cancer Immunotherapy
Wan, Z., Zheng, R., Moharil, P., Liu, Y., Chen, J., Sun, R., Song, X., & Ao, Q. (2021) · Molecules · doi:10.3390/molecules26051220 · Cited by 54
“When a body gets infected with a pathogen, interferons are produced to induce the activation and maturation of macrophages, lymphocytes, dendritic cells (DCs), and other immune cells [45].”
BackgroundToxicity as a result of immunostimulation by biologics
Gribble, E. J., Sivakumar, P. V., Ponce, R. A., & Hughes, S. D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.209 · Cited by 52
“The immunostimulatory activity of IFN-α includes upregulation of antiviral gene expression [148-150], suppression of cell proliferation [151,152], enhanced cytotoxic activity of macrophages, NK cells and neutrophils [153,154] and inhibition of viral replication [155-157].”
BackgroundAntiviral effect of interferon lambda against West Nile virus
Ma, D., Jiang, D., Qing, M., Weidner, J. M., Qu, X., Guo, H., Chang, J., Gu, B., Shi, P., Block, T. M., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.03.006 · Cited by 53
In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus
Livonesi, M. C., de Sousa, R. L. M., Badra, S. J., & Figueiredo, L. T. M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.01.158 · Cited by 53
Role of alcohol in pathogenesis of hepatitis B virus infection
Ganesan, M., Eikenberry, A., Poluektova, L. Y., Kharbanda, K. K., & Osna, N. A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i9.883 · Cited by 61
Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3
Delwar, Z. M., Kuo, Y., Wen, Y. H., Rennie, P. S., & Jia, W. W.-G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0599 · Cited by 53
Conditionally Replicating Adenoviruses for Cancer Treatment
Jounaïdi, Y., Doloff, J. C., & Waxman, D. J. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780618301 · Cited by 61
“protein synthesis shut-off as a response to viral infection [89],”
Immune Functions of Astrocytes in Viral Neuroinfections
Jorgačevski, J., & Potokar, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043514 · Cited by 56
Humlicek, A. L., Manzel, L. J., Chin, C. L., Shi, L., Excoffon, K. J. D. A., Winter, M. C., Shasby, D. M., & Look, D. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6395 · Cited by 51
“For subsequent experiments, we primarily focused on airway epithelial responses to type II IFN, as sensitive reagents for studying both receptor detection and activation are available, and the majority of IFN- is released in vivo by lymphocytes but not epithelial cells, thereby allowing precise control of stimulation…”
BackgroundMethodZhu, H., Nelson, D. R., Crawford, J. M., & Liu, C. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.528 · Cited by 53
“(15) Alternatively, an altered host environment may somehow favor viral survival.”
Menachery, V. D., Pasieka, T. J., & Leib, D. A. (2010) · Journal of Virology · doi:10.1128/jvi.00706-10 · Cited by 53
Song, Z., Zhang, Q., Liu, X., Bai, J., Zhao, Y., Wang, X., & Jiang, P. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.09.011 · Cited by 48
Wang, T., & Fikrig, E. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.05.008 · Cited by 47
“Interferons and innate immune responses to West Nile virus The type 1 interferons (IFNs), IFN-a and IFN-b, participate in the control of viral infections [21] and, in vitro, can partially protect fetal murine spinal cord tissues, neuroblastoma cells and primate cells from WN virus infection [22–24].”
BackgroundHu, G., Yin, X., Lou, H., Xia, J., Dong, X., Zhang, J., & Liu, Q. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.09.003 · Cited by 53
Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection
Nakayama, Y., Plisch, E. H., Sullivan, J. A., Thomas, C. B., Czuprynski, C. J., Williams, B. R. G., & Suresh, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000966 · Cited by 52
“proteins to neutralize PKR-independent IFN actions [14,55],”
BackgroundCarbone, C. J., Zheng, H., Bhattacharya, S., Lewis, J. R., Reiter, A. M., Henthorn, P. S., Zhang, Z., Baker, D. P., Ukkiramapandian, R., Bence, K. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211491109 · Cited by 55
“These cytokines elicit their antiviral effects by inducing IFN-stimulated genes (6, 7) whose transcription is activated as a result of a signal transduction pathway involving binding of IFN1 to its receptor [consisting of IFN-α/β receptor chain 1 (IFNAR1) and IFNAR2] followed by activation of Janus kinases (JAK; TYK2…”
BackgroundYu, L., Feng, Y., Li, Y.-Y., Zhan, Y., Liu, Y., Yan, H.-M., Fang, Y., Xie, Y., Zhang, F.-J., Chen, L., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz131 · Cited by 50
Stable Isotope Tagging of Epitopes
Meiring, H. D., Soethout, E. C., Poelen, M. C. M., Mooibroek, D., Hoogerbrugge, R., Timmermans, H., Boog, C. J. P., Heck, A. J. R., de Jong, A. P. J. M., & van Els, C. A. C. M. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500014-mcp200 · Cited by 47
“During viral infection, the MHC class I display of peptides is affected due to changes in host protein expression and as a result of the production of viral proteins (1, 2).”
BackgroundCurrent Development Status of Cytokines for Cancer Immunotherapy
Song, K. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.196 · Cited by 48
“They are largely divided into three types: Type I, which includes IFN- , IFN- , IFN-ω, and IFN-τ; Type II, which includes IFN-gamma; and the most recently recognized Type III, which includes IFN- (Katze et al ., 2002).”
Induction and sequencing of Rousette bat interferon α and β genes
Omatsu, T., Bak, E., Ishii, Y., Kyuwa, S., Tohya, Y., Akashi, H., & Yoshikawa, Y. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.03.004 · Cited by 52
Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets
Denizot, M., Neal, J. W., & Gasque, P. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.03.019 · Cited by 51
Morphine Suppresses IFN Signaling Pathway and Enhances AIDS Virus Infection
Wang, Y., Wang, X., Li, Y., Li, J., Li, S., Fulambarkar, N., & Ho, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031167 · Cited by 48
“Interferons (IFNs) are key players in host innate immunity, as they possess antiviral activity against a variety of viruses [24], including HIV [25,26].”
BackgroundWalton, R. W., Brown, M. C., Sacco, M. T., & Gromeier, M. (2018) · Journal of Virology · doi:10.1128/jvi.00879-18 · Cited by 49
“Many viral pathogens must intercept antiviral IFN responses to replicate in the face of activating innate immunity (29).”
BackgroundThe Function and Mechanism of Enterovirus 71 (EV71) 3C Protease
Wen, W., Qi, Z., & Wang, J. (2020) · Current Microbiology · doi:10.1007/s00284-020-02082-4 · Cited by 46
RNA silencing of rotavirus gene expression
Arias, C. F., Déctor, M. A., Segovia, L., López, T., Camacho-Nuez, M., Iša, P., Espinosa, R., & López, S. (2004) · Virus Research · doi:10.1016/j.virusres.2004.01.014 · Cited by 46
“In mammalian cells, dsRNA fragments longer than 30 bp induce components of the interferon response, including the dsRNA-dependent protein kinase (PKR), the 2 ,5 -oligoadenylate synthetase (OAS) and the non-specific RNAse L (Katze et al., 2002) .”
BackgroundMartin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45
“4e), consistent with the role of ISGs as antiviral effectors 11 .”
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.